ProteomeX LTQ Workstation Shared Instrumentation

ProteomeX LTQ 工作站共享仪器

• 批准号: 7044524
• 负责人: RONG WANG
• 金额: $ 42.41万
• 依托单位: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-03-15 至 2008-03-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7044524
• 关键词: ions; proteomics

DESCRIPTION (provided by applicant): This proposal requests a Finnigan ProteomeX LTQ workstation, an integrated chromatography electrospray ionization linear ion trap mass spectrometer to bring our Basic and Translational Proteomics Center / Shared Research Facility's analytical capability up to state-of-the-art and to increase our capacity to meet the ever increasing volume and intensity of work by our investigators. This request is essential to support our ongoing research programs and to stimulate and enable new collaborative research initiatives on protein identification, posttranslational modification characterization, gene discovery, and functional proteomics. Currently, there is no ESI-LTQ linear ion trap mass spectrometer at the Mount Sinai Medical Center (Hospital and School of Medicine), which provides a fundamental reason for this request. The ProteomeX LTQ workstation is requested in replace of our aged Finnigan LCQ classic mass spectrometer which breaks down so frequently that it seriously affects the on-going research projects. The requested ProteomeX LTQ linear ion trap mass spectrometer will be housed in our Basic and Translational Proteomics Center. The purchase of the ProteomeX LTQ linear ion trap mass spectrometer is fundamental to the continuing expansion and enhancement of the basic research programs and translational proteomics research for human disease on the Mount Sinai campus. As described in this application, over 22 NIH-funded investigators from 10 different departments and two NIH-funded investigators from neighboring institutes have specific needs for this mass spectrometer, which will be a shared research resource. Indeed, due to the lack of an highly sensitive and high throughput proteomics instrument on campus, some of these research projects are seriously delayed or compromised. Thus, the purchase of the ProteomeX LTQ system will have a major impact on the research capabilities at our institution.

描述（由申请人提供）：该提案要求Finnigan ProteomeX LTQ工作站，一个集成的色谱电喷雾电离线性离子阱质谱仪，使我们的基础和转化蛋白质组学中心/共享研究设施的分析能力达到最先进水平，并提高我们的能力，以满足我们的研究人员不断增加的工作量和强度。这一要求是必不可少的，以支持我们正在进行的研究计划，并刺激和使新的合作研究计划蛋白质鉴定，翻译后修饰表征，基因发现和功能蛋白质组学。目前，西奈山医学中心（医院和医学院）没有ESI-LTQ线性离子阱质谱仪，这是提出这一要求的根本原因。ProteomeX LTQ工作站被要求取代我们老化的Finnigan LCQ经典质谱仪，该质谱仪故障频繁，严重影响了正在进行的研究项目。所要求的ProteomeX LTQ线性离子阱质谱仪将被安置在我们的基础和翻译蛋白质组学中心。购买ProteomeX LTQ线性离子阱质谱仪是继续扩大和加强西奈山校区基础研究计划和人类疾病转化蛋白质组学研究的基础。如本申请所述，来自10个不同部门的22名NIH资助的研究人员和来自邻近研究所的两名NIH资助的研究人员对该质谱仪有特定需求，这将是一个共享的研究资源。事实上，由于缺乏一个高灵敏度和高通量的蛋白质组学仪器在校园里，这些研究项目中的一些是严重延误或妥协。因此，购买ProteomeX LTQ系统将对我们机构的研究能力产生重大影响。